Kriya Therapeutics develops gene therapies for prevalent diseases including diabetes, obesity, and ophthalmology with a vertically integrated discovery, manufacturing, and clinical-development platform. Patients with chronic conditions are the eventual customer base. Kriya operates GMP manufacturing facilities in-house rather than outsourcing.
acquisitions n=0
No cited completed company acquisition recorded.
traction n=0
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
valuations n=0
No cited valuation with an explicit basis is recorded.
revenue multiples n=0
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
Cloudflare, WordPress, Amazon Web Services, Matomo Analytics, Modernizr, Yoast SEO 27.4, Google Analytics, Google Tag Manager, Jabmo, jQuery Migrate 3.4.1, DoubleClick Floodlight, Choices